Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTPN2 pseudogene 1 (PTPN2P1) is a processed pseudogene corresponding to the *PTPN2* gene, which encodes tyrosine-protein phosphatase non-receptor type 2[4][1]. Pseudogenes are DNA sequences similar to normal genes but typically lack the ability to encode a functional protein. PTPN2P1 does not produce an active enzyme and, therefore, does not have direct biological functions, disease associations, therapeutic relevance, or interacting drugs. Information regarding active biological, pharmacological, or clinical properties relates to the functional gene *PTPN2*, not to its pseudogenes. If intent was to refer to the functional protein, it should be *PTPN2*, not PTPN2P1; PTPN2P1 is not considered a true drug target. If more information is required about the functional protein (PTPN2), that can be provided, but PTPN2P1 itself is not a relevant drug target or receptor[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PTPN2 pseudogene 1 (PTPN2P1).